Changes in medical use of central nervous system stimulants among US adults, 2013 and 2018: a cross-sectional study [PDF]
BMJ Open, 2021 Objective To assess the 5-year changes in the adult medical use of central nervous system (CNS) stimulants with higher risk of dependence and evaluate the population characteristics of users and their medical and/or neurological conditions.Design Cross ...
G Caleb Alexander +3 more
doaj +2 more sources
Medical use and combination drug therapy among US adult users of central nervous system stimulants: a cross-sectional analysis [PDF]
BMJ Open, 2023 Objective Examine patterns of adult medical use of amphetamine and methylphenidate stimulant drugs, classified in the USA as Schedule II controlled substances with a high potential for psychological or physical dependence.Design Cross-sectional study ...
G Caleb Alexander +3 more
doaj +2 more sources
Nitric oxide and cytokine production by glial cells exposed in vitro to neuropathogenic schistosome Trichobilharzia regenti [PDF]
Parasites & Vectors, 2016 Background Helminth neuroinfections represent a serious health problem, but host immune mechanisms in the nervous tissue often remain undiscovered. This study aims at in vitro characterization of the response of murine astrocytes and microglia exposed to
Tomáš Macháček +3 more
doaj +2 more sources
Central nervous system stimulants and sport practice. [PDF]
Br J Sports Med, 2006 Background and objectives:Central nervous system (CNS) stimulants may be used to reduce tiredness and increase alertness, competitiveness, and aggression. They are more likely to be used in competition but may be used during training to increase the intensity of the training session. There are several potential dangers involving their misuse in contact
Avois L +5 more
europepmc +4 more sources
The NOD (Naltrexone for Overdose Prevention) study protocol: a pilot randomized controlled trial of intramuscular naltrexone for opioid overdose prevention among people who use stimulants living with or at risk for HIV [PDF]
Addiction Science & Clinical PracticeBackground Drug-related mortality in the United States continues to transform, marked by a surge in overdose deaths involving both fentanyl and stimulants.
Ayesha Appa +8 more
doaj +2 more sources
Drug overdose deaths in Brazil between 2000 and 2020: an analysis of sociodemographics and intentionality [PDF]
Brazilian Journal of Psychiatry, 2023 Objectives: To examine drug overdose records in Brazil from 2000 to 2020, analyzing trends over time in overdoses and overall sociodemographic characteristics of the deceased. Methods: Using data from the Brazilian Mortality Information System (Sistema
Marina Costa Moreira Bianco +10 more
doaj +1 more source
Frontiers in Psychiatry, 2021 This study compares the efficacy and tolerability of central nervous system (CNS) stimulants in children with attention deficit hyperactivity disorder (ADHD) with and without prominent irritability (IRR) over the course of 30 months.
Raman Baweja +4 more
doaj +1 more source
Revista Mexicana de Neurociencia, 2022 Objective: The objective of the study was to know the opinion and prevalence of use of central nervous system stimulant drugs (SDs) in healthy people in open population.
Paulina Flores-Medina +1 more
doaj +1 more source
General overview on sleep medication [PDF]
Romanian Journal of Neurology, 2018 There are many medications that cross the blood-brain barrier affecting the central nervous system and converting the normal patterns of sleep and wakefulness. Some drugs are used to treat special sleep disorders, but others can induce sleep disorders (e.
Floriana Boghez, Ioana Mindruta
doaj +1 more source
Nootropics use in the workplace. Psychiatric and ethical aftermath towards the new frontier of bioengineering [PDF]
, 2020 OBJECTIVE: The authors have sought to expound upon and shed a light on the rise of nootropics, which have gradually taken on a more and more relevant role in workplaces and academic settings.
Bersani, G +5 more
core +1 more source